Get started
Author

Jacqueline Buchanan

Observed names: J Buchanan, J. Buchanan, JACQUELINE BUCHANAN
Observed institutions: Amgen (United States), Johnson & Johnson (United States), Frimley Park Hospital, East Surrey Hospital, Imperial College London, Stanford University
OpenAlex ID: A5113877419
Golimumab reduces sleep disturbance in patients with active ankylosing spondylitis: Results from a randomized, placebo‐controlled trial
2010 · Atul Deodhar, Jürgen Braun, et al. · Arthritis Care & Research · 67
Trends in the multiple myeloma treatment landscape and survival: a U.S. analysis using 2011–2019 oncology clinic electronic health record data
2020 · Megan Braunlin, Rajesh Belani, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 64
Effect of Golimumab on Patient-reported Outcomes in Rheumatoid Arthritis: Results from the GO-FORWARD Study
2012 · MARK C. GENOVESE, CHENGLONG HAN, et al. · The Journal of Rheumatology · 46
PDF
Cost-effectiveness of denosumab for the prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States
2019 · Alison Stopeck, Adam Brufsky, et al. · Journal of Medical Economics · 32
Cost effectiveness of golimumab for the treatment of active psoriatic arthritis
2011 · Ewen Cummins, Christian Asseburg, et al. · The European Journal of Health Economics · 20
How scoring limits the usability of minimal important differences (MIDs) as responder definition (RD): an exemplary demonstration using EORTC QLQ-C30 subscales
2022 · Kim Cocks, Jacqueline Buchanan · Quality of Life Research · 19
Economic burden of disease progression among multiple myeloma patients who have received transplant and at least one line of therapy in the US
2021 · Rafael Fonseca, May Hagiwara, et al. · Blood Cancer Journal · 14
PDF
Health Related Quality of Life Results from the Open-Label, Randomized, Phase III Endeavor Trial Evaluating Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma
2016 · Heinz Ludwig, Philippe Moreau, et al. · Blood · 10
Ms4 Golimumab Significantly Improves Productivity in Patients With Active Ankylosing Spondylitis: Results From the Phase 3 Go-raise Study
2008 · J Braun, RD Inman, et al. · Value in Health · 5
Response to Cost-Effectiveness Analysis of Zoledronic Acid Once Per Month, Zoledronic Acid Once Every 3 Months, and Denosumab Once Per Month in Women With Breast Cancer and Skeletal Metastases
2018 · Lisa Kennedy, Sumita Bhatta, et al. · Journal of Clinical Oncology · 4
Economic Burden of Disease Progression Among Transplant Eligible Multiple Myeloma Patients Who Have Received at Least One Line of Therapy in the US
2019 · Rafael Fonseca, May Hagiwara, et al. · Blood · 3
Golimumab Significantly Improves Physical Function and Fatigue in Ra Patients Previously Treated With Anti-tnf Agents: Results From the Go-after Study
2010 · Julia Kay, P Wordsworth, et al. · 3
Rheumatoid Arthritis: Treatment [151-201]: 151. Should we be Looking More Carefully for Methotrexate Induced Liver Disease?
2010 · M. Lloyd, R. Makadsi, et al. · Rheumatology · 2
Efficacy of treatments tested in COVID-19 patients with cardiovascular disease. A meta-analysis
2022 · Soumaya Ben-Aicha, Jacqueline Buchanan, et al. · Perfusion · 1
Trends in the Multiple Myeloma Treatment Landscape: A United States Analysis of Oscer Electronic Health Record Data 2011-2019
2019 · Megan Braunlin, Rajesh Belani, et al. · Blood · 1
Pcn133 a Systematic Literature Review of the Economic Burden of Newly Diagnosed Multiple Myeloma
2019 · D. Cizova, S. Panjabi, et al. · Value in Health · 1
Treatment patterns of melanoma by BRAF mutation status in the US in 2011-2017: A retrospective cohort study
2018 · L. Raskin, S. Shah, et al. · Annals of Oncology · 1
Humanistic burden of disease in earlier stage metastatic (stage IIIb/c-IVM1a) versus late stage metastatic (IVM1b/c) melanoma patients in a real-world setting in the U.S.
2017 · Jacqueline Buchanan, Swaminathan Murugappan, et al. · Journal of Clinical Oncology · 1
Superior Health-Related Quality of Life with Carfilzomib, Lenalidomide, and Dexamethasone versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple Myeloma (MM): Results From the ASPIRE Trial
2015 · A.K. Stewart, M.A. Dimopoulos, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
Psy38 Cost-effectiveness of Golimumab in Ankylosing Spondylitis From the Uk Payer Perspective
2010 · N Muszbek, Y Punekar, et al. · Value in Health · 1
PDF
Spondyloarthropathies (Including Psoriatic Arthritis) [40-69]: 40. Eagle's Syndrome: An Unusual Association with Sero-Negative Arthropathy
2010 · S. Wig, P. Bischoff, et al. · Rheumatology · 1
Pms29 Golimumab Significantly Reduces Time Lost From Work for Patients With Rheumatoid Arthritis: Pooled Results From Three Phase 3 Studies
2009 · J Buchanan, P Emery, et al. · Value in Health · 1
Pms43 Golimumab, a Human Anti-tnf-alpha Monoclonal Antibody, Significantly Reduces Time Lost From Work for Patients With Rheumatoid Arthritis: Pooled Results Fromthree Phase 3 Studies
2008 · J Buchanan, P Emery, et al. · Value in Health · 1
PDF
Diagnostic Nuclear Medicine : Patient Studies
1987 · Henry N. Wagner, Jacqueline Buchanan, et al. · 1
Meta-Analysis of COVID-19 treatments on patients with a previous diagnosis of cardiovascular disease
2021 · S Ben-Aicha, J Buchanan, et al. · European Heart Journal
PDF
Works count: 34
Citation count: 302
H-index: 8
I10-index: 8
Year
Topic
Type